Cargando…

The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study

BACKGROUND: Complementary and alternative medicine (CAM) use is common among cancer patients. This paper reviews the use of CAM in a series of patients with locally advanced breast cancer (LABC). METHODS: Women with LABC attending a specialist clinic at a single Canadian cancer centre were identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Helyer, Lucy K, Chin, Stephen, Chui, Betty K, Fitzgerald, Barbara, Verma, Sunil, Rakovitch, Eileen, Dranitsaris, George, Clemons, Mark
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475605/
https://www.ncbi.nlm.nih.gov/pubmed/16504038
http://dx.doi.org/10.1186/1471-2407-6-39
_version_ 1782128124276768768
author Helyer, Lucy K
Chin, Stephen
Chui, Betty K
Fitzgerald, Barbara
Verma, Sunil
Rakovitch, Eileen
Dranitsaris, George
Clemons, Mark
author_facet Helyer, Lucy K
Chin, Stephen
Chui, Betty K
Fitzgerald, Barbara
Verma, Sunil
Rakovitch, Eileen
Dranitsaris, George
Clemons, Mark
author_sort Helyer, Lucy K
collection PubMed
description BACKGROUND: Complementary and alternative medicine (CAM) use is common among cancer patients. This paper reviews the use of CAM in a series of patients with locally advanced breast cancer (LABC). METHODS: Women with LABC attending a specialist clinic at a single Canadian cancer centre were identified and approached. Participants completed a self-administered survey regarding CAM usage, beliefs associated with CAM usage, views of their risks of developing recurrent cancer and of dying of breast cancer. Responses were scored and compared between CAM users and non-users. RESULTS: Thirty-six patients were approached, 32 completed the questionnaire (response rate 89%). Forty-seven percent of LABC patients were identified as CAM users. CAM users were more likely to be younger, married, in a higher socioeconomic class and of Asian ethnicity than non-users. CAM users were likely to use multiple modalities simultaneously (median 4) with vitamins being the most popular (60%). Motivation for CAM therapy was described as, "assisting their body to heal" (75%), to 'boost the immune system' (56%) and to "give a feeling of control with respect to their treatment" (56%). CAM therapy was used concurrently with conventional treatment in 88% of cases, however, 12% of patients felt that CAM could replace their conventional therapy. Psychological evaluation suggests CAM users perceived their risk of dying of breast cancer was similar to that of the non-Cam group (33% vs. 35%), however the CAM group had less severe anxiety and depression. CONCLUSION: The motivation, objectives and benefits of CAM therapy in a selected population of women with LABC are similar to those reported for women diagnosed with early stage breast cancer. CAM users display less anxiety and depression and are less likely to believe they will die of their breast cancer. However the actual benefit to overall and disease free survival has yet to be demonstrated, as well as the possible interactions with conventional therapy. Consequently more research is needed in this ever-growing field.
format Text
id pubmed-1475605
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14756052006-06-08 The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study Helyer, Lucy K Chin, Stephen Chui, Betty K Fitzgerald, Barbara Verma, Sunil Rakovitch, Eileen Dranitsaris, George Clemons, Mark BMC Cancer Research Article BACKGROUND: Complementary and alternative medicine (CAM) use is common among cancer patients. This paper reviews the use of CAM in a series of patients with locally advanced breast cancer (LABC). METHODS: Women with LABC attending a specialist clinic at a single Canadian cancer centre were identified and approached. Participants completed a self-administered survey regarding CAM usage, beliefs associated with CAM usage, views of their risks of developing recurrent cancer and of dying of breast cancer. Responses were scored and compared between CAM users and non-users. RESULTS: Thirty-six patients were approached, 32 completed the questionnaire (response rate 89%). Forty-seven percent of LABC patients were identified as CAM users. CAM users were more likely to be younger, married, in a higher socioeconomic class and of Asian ethnicity than non-users. CAM users were likely to use multiple modalities simultaneously (median 4) with vitamins being the most popular (60%). Motivation for CAM therapy was described as, "assisting their body to heal" (75%), to 'boost the immune system' (56%) and to "give a feeling of control with respect to their treatment" (56%). CAM therapy was used concurrently with conventional treatment in 88% of cases, however, 12% of patients felt that CAM could replace their conventional therapy. Psychological evaluation suggests CAM users perceived their risk of dying of breast cancer was similar to that of the non-Cam group (33% vs. 35%), however the CAM group had less severe anxiety and depression. CONCLUSION: The motivation, objectives and benefits of CAM therapy in a selected population of women with LABC are similar to those reported for women diagnosed with early stage breast cancer. CAM users display less anxiety and depression and are less likely to believe they will die of their breast cancer. However the actual benefit to overall and disease free survival has yet to be demonstrated, as well as the possible interactions with conventional therapy. Consequently more research is needed in this ever-growing field. BioMed Central 2006-02-21 /pmc/articles/PMC1475605/ /pubmed/16504038 http://dx.doi.org/10.1186/1471-2407-6-39 Text en Copyright © 2006 Helyer et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Helyer, Lucy K
Chin, Stephen
Chui, Betty K
Fitzgerald, Barbara
Verma, Sunil
Rakovitch, Eileen
Dranitsaris, George
Clemons, Mark
The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
title The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
title_full The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
title_fullStr The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
title_full_unstemmed The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
title_short The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
title_sort use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475605/
https://www.ncbi.nlm.nih.gov/pubmed/16504038
http://dx.doi.org/10.1186/1471-2407-6-39
work_keys_str_mv AT helyerlucyk theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT chinstephen theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT chuibettyk theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT fitzgeraldbarbara theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT vermasunil theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT rakovitcheileen theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT dranitsarisgeorge theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT clemonsmark theuseofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT helyerlucyk useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT chinstephen useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT chuibettyk useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT fitzgeraldbarbara useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT vermasunil useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT rakovitcheileen useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT dranitsarisgeorge useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy
AT clemonsmark useofcomplementaryandalternativemedicinesamongpatientswithlocallyadvancedbreastcanceradescriptivestudy